Angiodynamic 

$9.49
0
-$2.45-20.52% Tuesday 04:00

Statistics

Day High
9.49
Day Low
9.49
52W High
-
52W Low
-
Volume
6
Avg. Volume
-
Mkt Cap
391.15M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

2AprExpected
Q4 2025
Q1 2026
-0.11
-0.07
-0.02
0.02
Expected EPS
-0.11
Actual EPS
0.02

Financials

-11.62%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
585MRevenue
-67.99MNet Income

Analyst Ratings

$16.00Average Price Target
The highest estimate is 16.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ANGO.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Boston Scientific
BSX
Mkt Cap93.36B
Boston Scientific competes in the medical devices sector, offering products in various areas including vascular therapy, which overlaps with AngioDynamics' offerings.
Medtronic
MDT
Mkt Cap111.22B
Medtronic is a global leader in medical technology, services, and solutions, with a broad range of products that compete directly with AngioDynamics' vascular and oncology portfolios.
Baxter International
BAX
Mkt Cap8.61B
Baxter International operates in the critical care, nutrition, renal, hospital, and surgical products sectors, competing with AngioDynamics in the infusion and oncology product lines.
Abbott Laboratories
ABT
Mkt Cap178.76B
Abbott Laboratories offers medical devices, diagnostics, branded generic medicines, and nutritional products, competing with AngioDynamics in the cardiovascular and vascular access segments.
Johnson & Johnson
JNJ
Mkt Cap585.7B
Johnson & Johnson, through its medical devices segment, competes in the surgical, orthopedic, and cardiovascular markets, overlapping with AngioDynamics' surgical and oncology products.
ICU Medical
ICUI
Mkt Cap3.04B
ICU Medical is involved in the development, manufacture, and sale of innovative medical devices used in vascular therapy, oncology, and critical care applications, competing with AngioDynamics.
Hologic
HOLX
Mkt Cap16.89B
Hologic specializes in diagnostics, medical imaging systems, and surgical products for women's health, competing with AngioDynamics in the diagnostics and treatment of diseases.
Smith & Nephew
SNN
Mkt Cap13.72B
Smith & Nephew specializes in advanced wound management, orthopedics, and endoscopy, indirectly competing with AngioDynamics in the surgical and wound care markets.

About

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers' off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, diagnostic and interventional guidewires, and coaxial micro-introducer kits for use in peripheral diagnostic and interventional procedures. In addition, the company provides abscession drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-access kits offer interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.
Show more...
CEO
ISIN
US03475V1017

Listings

0 Comments

Share your thoughts

FAQ

What is Angiodynamic stock price today?
The current price of ANGO.BOATS is $9.49 USD — it has decreased by -20.52% in the past 24 hours. Watch Angiodynamic stock price performance more closely on the chart.
What is Angiodynamic stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Angiodynamic stocks are traded under the ticker ANGO.BOATS.
What is Angiodynamic market cap?
Today Angiodynamic has the market capitalization of 391.15M
When is the next Angiodynamic earnings date?
Angiodynamic is going to release the next earnings report on July 21, 2026.
What were Angiodynamic earnings last quarter?
ANGO.BOATS earnings for the last quarter are 0.02 USD per share, whereas the estimation was -0.11 USD resulting in a +118.18% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Angiodynamic revenue for the last year?
Angiodynamic revenue for the last year amounts to 585M USD.
What is Angiodynamic net income for the last year?
ANGO.BOATS net income for the last year is -67.99M USD.
When did Angiodynamic complete a stock split?
Angiodynamic has not had any recent stock splits.